Clinical Trial Update: Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). [Phase 2]

View source ↗

Summary

A Phase 2 trial investigates thoracic radiotherapy with maintenance durvalumab after first-line carboplatin and etoposide plus durvalumab in extensive-stage sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IMFINZI (DURVALUMAB)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Small Cell Lung Cancer, Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING